A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2015
At a glance
- Drugs Saracatinib (Primary)
- Indications Dermatofibrosarcoma; Leiomyosarcoma; Liposarcoma; Rhabdomyosarcoma; Soft tissue sarcoma; Uterine leiomyoma
- Focus Therapeutic Use
- 07 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 May 2008 New trial record.